Literature DB >> 22448726

Influence of the carboxy terminus of serum amyloid A on protein oligomerization, misfolding, and fibril formation.

Sanket Patke1, Ronak Maheshwari, Jeffrey Litt, Saipraveen Srinivasan, J Javier Aguilera, Wilfredo Colón, Ravi S Kane.   

Abstract

The fibrillar deposition of serum amyloid A (SAA) has been linked to the disease amyloid A (AA) amyloidosis. We have used the SAA isoform, SAA2.2, from the CE/J mouse strain, as a model system to explore the inherent structural and biophysical properties of SAA. Despite its nonpathogenic nature in vivo, SAA2.2 spontaneously forms fibrils in vitro, suggesting that SAA proteins are inherently amyloidogenic. However, whereas the importance of the amino terminus of SAA for fibril formation has been well documented, the influence of the proline-rich and presumably disordered carboxy terminus remains poorly understood. To clarify the inherent role of the carboxy terminus in the oligomerization and fibrillation of SAA, we truncated the proline-rich final 13 residues of SAA2.2. We found that unlike full-length SAA2.2, the carboxy-terminal truncated SAA2.2 (SAA2.2ΔC) did not oligomerize to a hexamer or octamer, but formed a high molecular weight soluble aggregate. Moreover, SAA2.2ΔC also exhibited a pronounced decrease in the rate of fibril formation. Intriguingly, when equimolar amounts of denatured SAA2.2 and SAA2.2ΔC were mixed and allowed to refold together, the mixture formed an octamer and exhibited rapid fibrillation kinetics, similar to those for full-length SAA2.2. These results suggest that the carboxy terminus of SAA, which is highly conserved among SAA sequences in all vertebrates, might play important structural roles, including modulating the folding, oligomerization, misfolding, and fibrillation of SAA.
© 2012 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22448726      PMCID: PMC3332083          DOI: 10.1021/bi201903s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  49 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

Review 2.  Pathology, diagnosis and pathogenesis of AA amyloidosis.

Authors:  Christoph Röcken; Ann Shakespeare
Journal:  Virchows Arch       Date:  2002-02       Impact factor: 4.064

3.  Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

Authors:  Rakez Kayed; Elizabeth Head; Jennifer L Thompson; Theresa M McIntire; Saskia C Milton; Carl W Cotman; Charles G Glabe
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

Review 4.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.

Authors:  Byron Caughey; Peter T Lansbury
Journal:  Annu Rev Neurosci       Date:  2003-04-09       Impact factor: 12.449

5.  A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey.

Authors:  Serhan Tuglular; Fatos Yalcinkaya; Saime Paydas; Ayse Oner; Cengiz Utas; Semra Bozfakioglu; Rezzan Ataman; Tekin Akpolat; Ercan Ok; Saniye Sen; Ruhan Düsünsel; Rifki Evrenkaya; Emel Akoglu
Journal:  Nephrol Dial Transplant       Date:  2002-11       Impact factor: 5.992

6.  Circular dichroism analyses of membrane proteins: an examination of differential light scattering and absorption flattening effects in large membrane vesicles and membrane sheets.

Authors:  B A Wallace; D Mao
Journal:  Anal Biochem       Date:  1984-11-01       Impact factor: 3.365

7.  Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.

Authors:  J D Gillmore; L B Lovat; M R Persey; M B Pepys; P N Hawkins
Journal:  Lancet       Date:  2001-07-07       Impact factor: 79.321

8.  Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3.

Authors:  B Stix; T Kähne; K Sletten; J Raynes; A Roessner; C Röcken
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

9.  Serum amyloid A in Alzheimer's disease brain is predominantly localized to myelin sheaths and axonal membrane.

Authors:  T F Chung; J D Sipe; A McKee; R E Fine; B M Schreiber; J S Liang; R J Johnson
Journal:  Amyloid       Date:  2000-06       Impact factor: 7.141

10.  Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel.

Authors:  Limin Wang; Hilal A Lashuel; Thomas Walz; Wilfredo Colon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

View more
  4 in total

Review 1.  Serum amyloid A1: Structure, function and gene polymorphism.

Authors:  Lei Sun; Richard D Ye
Journal:  Gene       Date:  2016-03-03       Impact factor: 3.688

2.  Influence of C-terminal truncation of murine Serum amyloid A on fibril structure.

Authors:  Matthies Rennegarbe; Inga Lenter; Angelika Schierhorn; Romy Sawilla; Christian Haupt
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

3.  Characterization of the oligomerization and aggregation of human Serum Amyloid A.

Authors:  Sanket Patke; Saipraveen Srinivasan; Ronak Maheshwari; Sunit K Srivastava; J Javier Aguilera; Wilfredo Colón; Ravi S Kane
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

4.  Variation of amino acid sequences of serum amyloid a (SAA) and immunohistochemical analysis of amyloid a (AA) in Japanese domestic cats.

Authors:  Meina Tei; Kazuyuki Uchida; James K Chambers; Ken-Ichi Watanabe; Takashi Tamamoto; Koichi Ohno; Hiroyuki Nakayama
Journal:  J Vet Med Sci       Date:  2017-12-04       Impact factor: 1.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.